Why the study?
Does high-dose atorvastatin improve carotid artery distensibility in patients with asymptomatic carotid artery disease compared to low-dose atorvastatin?
Does high-dose atorvastatin improve carotid artery distensibility in patients with asymptomatic carotid artery disease compared to low-dose atorvastatin?
High-dose atorvastatin (80 mg) significantly improves carotid arterial stiffness compared to low-dose (10 mg) over 12 weeks in patients with asymptomatic carotid artery disease.
Answers are grounded in this paper and cite their sources.
High-dose atorvastatin improves carotid compliance versus low-dose in asymptomatic disease; extends evidence for intensive statin effects on arterial stiffness.
AIM: To assess the effect of low-(10 mg) or high-(80 mg) dose atorvastatin on carotid artery distensibility in patients with asymptomatic carotid artery disease using carotid magnetic resonance imaging. METHODS: Eighteen patients underwent initial 2-dimensional ECG gated-phase contrast carotid MR imaging and off-line applanation tonometry for distensibility assessment before randomisation to receive low- or high-dose statins and this was repeated at 12 weeks. Phase and magnitude images from the 2-D phase contrast acquisitions were used for quantification of distensibility and compliance coefficients and were compared between the low- and high-dose statin groups. RESULTS: Both groups were comparable with regards to their demographics, co-morbidities and baseline cholesterol levels. After 12 weeks of high-dose statin administration, a significant decrease in LDL (p=0.003) and CRP (p=0.03) was observed. At 12 weeks, the distensibility coefficient of the common and internal carotid artery was found to be significantly higher (with respect to baseline) in the high-dose group (p=0.004 and p=0.007, respectively). The compliance coefficient was likewise found to be raised in the high-dose group when compared with the low-dose group [common carotid (p=0.002), internal carotid (p=0.009)]. CONCLUSIONS: High-dose atorvastatin tends to reduce carotid arterial stiffness, as suggested by increased distensibility and compliance coefficients; however, these results need validation through large-scale trials to fully establish their possible use in clinical practice.
No takes yet. Share an insight, caveat, or question.
Sadat et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: